March | 2020 | Profusa, Inc.

In the European Union, the Lumee™ Oxygen Platform is CE Marked. In the United States, the Lumee Oxygen Platform is an Investigational Device Limited by Federal Law to Investigational Use.

News & Events

For media inquiries, please contact [email protected].

Profusa and Partners Announce Initiation of Study to Measure Early Signs of Influenza Through Biosensor Technology

March 3, 2020

DARPA-Backed Study Leverages Profusa’s Lumee® Oxygen Platform as Part of a Larger Effort to Speed Detection and Predict Disease Outbreaks EMERYVILLE, Calif., March 3, 2020 – Profusa, a digital health company that is pioneering the ...